Alternative vs. conventional treatment given on-demand for gastroesophageal reflux disease: A randomised controlled trial

BMC Complementary and Alternative Medicine

Volumn 9, Issue , 2009, Pages

  Farup, Per G ^a,b   Heibert, Mathis ^c   Høeg, Victor ^a  

^a INNLANDET HOSPITAL TRUST   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c Nord Trøndelag University College   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AFLURAX; ESOMEPRAZOLE; GASTROINTESTINAL AGENT; PECTIN; UNCLASSIFIED DRUG; ANTIULCER AGENT; BICARBONATE; MAGNESIUM; MAGNESIUM CARBONATE; OMEPRAZOLE; POTASSIUM BICARBONATE; POTASSIUM DERIVATIVE;

ALTERNATIVE MEDICINE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; GASTROESOPHAGEAL REFLUX; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OPEN STUDY; PARALLEL DESIGN; PATIENT SATISFACTION; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SYMPTOMATOLOGY; ADULT; FEMALE; MALE; MIDDLE AGED;

ADULT; ANTI-ULCER AGENTS; BICARBONATES; COMPLEMENTARY THERAPIES; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MAGNESIUM; MALE; MIDDLE AGED; OMEPRAZOLE; PATIENT SATISFACTION; PECTINS; POTASSIUM COMPOUNDS;

EID: 63049135778     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-9-3     Document Type: Article

References (16)

1. Pace F Tonini M Pallotta S Molteni P Porro GB Systematic review: maintenance treatment of gastro-oesophageal reflux disease with proton pump inhibitors taken 'on-demand' Aliment Pharmacol Ther 2007, 26:195-204 17593065
2. Bardhan KD Intermittent and on-demand use of proton pump inhibitors in the management of symptomatic gastroesophageal reflux disease Am J Gastroenterol 2003, 98:S40-S48 10.1016/S0002-9270(03)00014-5 12644030
3. Jones R Bytzer P Acid suppression in the management of gastro-oesophageal reflux disease - an appraisal of treatment options in primary care Aliment Pharmacol Ther 2001, 15:765-772 10.1046/ j.1365-2036.2001.00985.x 11380314
4. Gerson LB Robbins AS Garber A Hornberger J Triadafilopoulos G A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease Am J Gastroenterol 2000, 95:395-407 10.1111/j.1572-0241.2000.01759.x 10685741
5. Zacny J Zamakhshary M Sketris I Veldhuyzen van Zanten S Systematic review: The efficacy of intermittent and on-demand therapy with histamine H2-receptor antagonists or proton pump inhibitors for gastro-oesophageal reflux disease patients Aliment Pharmacol Ther 2005, 21:1299-1312 10.1111/j.1365-2036.2005.02490.x 15932360
6. Hungin AP Rubin G O'Flanagan H Factors influencing compliance in long-term proton pump inhibitor therapy in general practice Br J Gen Pract 1999, 49:463-464 1313445 10562747
7. Van Soest EM Siersema PD Dieleman JP Sturkenboom MCJM Kuipers EJ Persistence and adherence to proton pump inhibitors in daily clinical practice Aliment Pharmacol Ther 2006, 24:377-385 10.1111/ j.1365-2036.2006.02982.x 16842465
8. Norman Hansen A Bergheim R Fagertun H Lund H Moum B A randomised prospective study comparing the effectiveness of esomeprazole treatment strategies in clinical practice for 6 months in the management of patients with symptoms of gastroesophageal reflux disease Int J Clin Pract 2005, 59:665-671 10.1111/j.1368-5031.2005.00564.x 15924594
9. Havelund T Aalykke C Rasmussen L Efficacy of a pectin-based anti-reflux agent on acid reflux and recurrence of symptom and oesophagitis in gastro-oesophageal reflux disease Eur J Gastroenterol Hepatol 1997, 9:509-514 9187886
10. Washington N Wilson CG Greaves JL Danneskiold-Samsøe P An Investigation into the Floating Behaviour of a Pectin-Containing Anti-Reflux Formulation (FF5005) by Means of Gamma Scintigraphy Scand J Gastroenterol 1988, 23:920-924 10.3109/00365528809090147 3201128
11. Havelund T Aalykke C The Efficacy of a Pectin-Based Raft-Forming Anti Reflux Agent in Endoscopy-Negative Reflux Disease Scand J Gastroenterol 1997, 32:773-777 10.3109/00365529708996533 9282968
12. Waterhouse ET Washington C Washington N An investigation into the efficacy of the pectin based anti-reflux formulation-Aflurax Int J Pharm 2000, 209:79-85 10.1016/S0378-5173(00)00556-1 11084248
13. Revicki DA Wood M Wiklund I Crawley J Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux disease Qual Life Res 1998, 7:75-83 10.1023/A:1008841022998 9481153
14. Hayden CW Bernstein CN Hall RA Vakil N Garewal HS Fass R Usage of supplemental alternative medicine by community-based patients with gastroesophageal reflux disease (GERD) Dig Dis Sci 2002, 47:1-8 10.1023/ A:1013264730992 11837707
15. Dettmar PW Sykes J Little SL Bryan J Rapid onset of effect of sodium alginate on gastro-oesophageal reflux compared with ranitidine and omeprazole, and relationship between symptoms and reflux episodes Int J Clin Pract 2006, 60:275-283 10.1111/j.1368-5031.2006.00800.x 16494641
16. Bytzer P On-demand therapy for gastro-oesophageal reflux disease Eur J Gastroenterol Hepatol 2001, 13:s19-s22 11430504